BILL COLONE
CEO, SINGLE PASS
WHY: Medical device executive turns ideas of doctors into products.
IN THE NEWS: Received regulatory approval in April for biopsy closure device five months after receiving clearance in the European Union.
NOTABLE: Said there’s a “very high probability” for an exit before the end of the calendar year.
QUOTABLE: “Our company is only [3 years] old, so it’s really fast to have both the CE mark and FDA clearance in that short of a time frame for a brand-new medical device company.”
